Since the decreased protein expression, transcriptional activity and target genes expressions of PPARα could be ameliorated by salidroside in cardiomyocyte hypertrophy, which were cancelled by PPARα knockdown, suggesting that PPARα plays an important role in the anti-cardiac hypertrophy effect of salidroside. The gene discussed is PPARA; the disease is cardiac hypertrophy.